Stonebridge Capital Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-272
Closed -$1.48K 587
2023
Q3
$1.48K Hold
272
﹤0.01% 834
2023
Q2
$2.52K Hold
272
﹤0.01% 793
2023
Q1
$2.23K Buy
272
+6
+2% +$66 ﹤0.01% 802
2022
Q4
$2.96K Buy
266
+7
+3% +$81 ﹤0.01% 759
2022
Q3
$3K Buy
259
+5
+2% +$76 ﹤0.01% 752
2022
Q2
$4K Buy
254
+248
+4,133% +$4.46K ﹤0.01% 732
2022
Q1
$0 Hold
6
﹤0.01% 1070
2021
Q4
$0 Sell
6
-61
-91% -$1.31K ﹤0.01% 1013
2021
Q3
$1K Buy
+67
New +$1.37K ﹤0.01% 902

Other funds holding MPT

Stonebridge Capital Advisors's MPT Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Medical Properties Trust (MPT) in Q4 2023, closing a stake of 272 shares — an estimated $1.48K sold.

Stonebridge Capital Advisors first reported a position in MPT in Q3 2021 and held it in 9 quarters. The position peaked at $4K in Q2 2022. 551 funds tracked by Wall St. Rank hold MPT as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Medical Properties Trust position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 272 Medical Properties Trust shares in Q4 2023, an estimated $1.48K.
  • Stonebridge Capital Advisors first reported a position in Medical Properties Trust in Q3 2021 and held it in 9 quarters.
  • Stonebridge Capital Advisors's Medical Properties Trust position peaked at $4K in Q2 2022.
  • 551 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.